Disclosure of interest: Juan David Riveros nothing to disclose, Paula Barrantes Silman nothing to disclose, Isamar Perez Andrade nothing to disclose, Miguel A Barboza nothing to disclose, E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.04 - THROMBOLYSIS P2146 - ESOC25-2502 FUNCTIONAL OUTCOMES IN ELDERLY ACUTE ISCHEMIC STROKE PATIENTS AFTER IV THROMBOLYSIS: SINGLE CENTER EXPERIENCE IN COSTA RICA Barrantes-Silman Paula 1 , Juan-David Riveros 1 , Perez-Andrade Isamar 1 , Barboza Miguel A
Berardis DD, Orsolini L, Iasevoli F, Tomasetti C, Mazza M, Valchera A, et al
At my clinic, we use glutathione injections in a variety of treatments
Duration of NFT-dependent increase in glutathione levels To determine the duration and the response of glutathione following withdrawal and re-addition of NFT, HepG2 cells were treated with NFT (20 M) for 48 h, followed by withdrawal of NFT for 24 h and a subsequent re-addition of NFT for an additional period of 24 h (Fig